These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Neutralizing the Threat: Pan-Ebolavirus Antibodies Close the Loop. Mire CE; Geisbert TW Trends Mol Med; 2017 Aug; 23(8):669-671. PubMed ID: 28697885 [TBL] [Abstract][Full Text] [Related]
11. Ebola: The great ape gamble. Willyard C Nature; 2017 Mar; 543(7647):S56-S57. PubMed ID: 28355186 [No Abstract] [Full Text] [Related]
12. Immunology of protection from Ebola virus infection. Krause PR; Bryant PR; Clark T; Dempsey W; Henchal E; Michael NL; Regules JA; Gruber MF Sci Transl Med; 2015 May; 7(286):286ps11. PubMed ID: 25947159 [TBL] [Abstract][Full Text] [Related]
13. A DNA vaccine for the prevention of Ebola virus infection. Dery M; Bausch DG Curr Opin Mol Ther; 2008 Jun; 10(3):285-93. PubMed ID: 18535936 [TBL] [Abstract][Full Text] [Related]
14. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus. Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083 [TBL] [Abstract][Full Text] [Related]
16. A single shot against Ebola and Marburg virus. Baize S Nat Med; 2005 Jul; 11(7):720-1. PubMed ID: 16015361 [No Abstract] [Full Text] [Related]
17. First Ebola virus vaccine to protect human beings? Geisbert TW Lancet; 2017 Feb; 389(10068):479-480. PubMed ID: 28017402 [No Abstract] [Full Text] [Related]
18. How Ebola-vaccine success could reshape clinical-trial policy. Butler D; Callaway E; Check Hayden E Nature; 2015 Aug; 524(7563):13-4. PubMed ID: 26245556 [No Abstract] [Full Text] [Related]
19. Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine. Zhou Y; Sullivan NJ Curr Opin Immunol; 2015 Aug; 35():131-6. PubMed ID: 26247875 [TBL] [Abstract][Full Text] [Related]
20. Open-label phase I clinical trial of Ad5-EBOV in Africans in China. Wu L; Zhang Z; Gao H; Li Y; Hou L; Yao H; Wu S; Liu J; Wang L; Zhai Y; Ou H; Lin M; Wu X; Liu J; Lang G; Xin Q; Wu G; Luo L; Liu P; Shentu J; Wu N; Sheng J; Qiu Y; Chen W; Li L Hum Vaccin Immunother; 2017 Sep; 13(9):2078-2085. PubMed ID: 28708962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]